results of retatrutide weight loss phase 2 trial Retatrutide: A Triple Agonist Shaping the Future Metabolic Care Lost 50lbs in 3 months!

When to Delay Dose Escalation Hold your current retatrutide dose and don't escalate if you experience: Persistent nausea or vomiting (more than 3 days after injection) Severe constipation or diarrhea Significant injection site reactions Rapid weight loss (more than 3-4 lbs/week consistently) Signs of dehydration from GI symptoms It's acceptable to remain at a dose longer than 4 weeks if needed

Commercial launch performance of oral GLP-1 therapies

Results demonstrated clear dose-dependent weight loss with a remarkably linear progression

However, berberine did improve blood sugar and cholesterol numbers

There are evidence that microglial cells also secrete GLP-1 in mice

LeeYSDeVadder FTremaroliVWichmannAMithieuxGBackhedF